FRIDAY, June 6, 2025 (HealthDay News) -- For patients who undergo percutaneous coronary intervention (PCI) and discontinue dual antiplatelet therapy (DAPT), P2Y
P2Y12 Inhibitor Monotherapy Beneficial for Patients Who Undergo PCI

58 0
FRIDAY, June 6, 2025 (HealthDay News) -- For patients who undergo percutaneous coronary intervention (PCI) and discontinue dual antiplatelet therapy (DAPT), P2Y